Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study completed to compare generic haloperidol tablets with the brand-name Haldol in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Haldol (haloperidol)
  • Haloperidol (generic) (haloperidol)

Snippet

Sponsor: Sandoz | Conditions: Psychosis | Phase 1 | Status: COMPLETED